APA
Mita T., Katakami N., Shiraiwa T., Yoshii H., Onuma T., Kuribayashi N., Osonoi T., Kaneto H., Kosugi K., Umayahara Y., Yamamoto T., Matsumoto K., Yokoyama H., Tsugawa M., Gosho M., Shimomura I. & Watada H. (20140314). Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE). : Diabetology & metabolic syndrome.
Chicago
Mita Tomoya, Katakami Naoto, Shiraiwa Toshihiko, Yoshii Hidenori, Onuma Tomio, Kuribayashi Nobuichi, Osonoi Takeshi, Kaneto Hideaki, Kosugi Keisuke, Umayahara Yutaka, Yamamoto Tsunehiko, Matsumoto Kazunari, Yokoyama Hiroki, Tsugawa Mamiko, Gosho Masahiko, Shimomura Iichiro and Watada Hirotaka. 20140314. Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE). : Diabetology & metabolic syndrome.
Harvard
Mita T., Katakami N., Shiraiwa T., Yoshii H., Onuma T., Kuribayashi N., Osonoi T., Kaneto H., Kosugi K., Umayahara Y., Yamamoto T., Matsumoto K., Yokoyama H., Tsugawa M., Gosho M., Shimomura I. and Watada H. (20140314). Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE). : Diabetology & metabolic syndrome.
MLA
Mita Tomoya, Katakami Naoto, Shiraiwa Toshihiko, Yoshii Hidenori, Onuma Tomio, Kuribayashi Nobuichi, Osonoi Takeshi, Kaneto Hideaki, Kosugi Keisuke, Umayahara Yutaka, Yamamoto Tsunehiko, Matsumoto Kazunari, Yokoyama Hiroki, Tsugawa Mamiko, Gosho Masahiko, Shimomura Iichiro and Watada Hirotaka. Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE). : Diabetology & metabolic syndrome. 20140314.